Spinal Cord Injury Human Trials Delayed

Work on Geron’s proposed stem cell treatment for spinal cord injury GRNOPC1, was stalled this week, as the FDA placed a clinical hold on the study.

With a 20,000+ page Investigational New Drug Application submitted, it’s bound to take some time determining how to monitor the studies.

At this point, Geron has not received the written explanation for the clinical hold. Thomas Okarma, Geron’s president and chief executive stated, “Once we have the letter and have had a discussion with the agency, we will communicate our finding and our thinking to shareholders.”

It would be fantastic if the study was steamrolled through.. found successful, and I had gained back my independence. We all know that this is going to be just one more long, patient wait though. Spinal cord injured individuals are accustomed to that.

I do  agree with Don Reed of stemcellbattles though.  If this is some devastating restriction in the 25th hour, supporters of this research must be ready to fight.